Athersys
Pre-clinicalAthersys develops regenerative medicine therapies, including MultiStem cell therapy for neurological, inflammatory, and cardiovascular conditions.
Founded
1995
Focus
BiologicsCell & Gene Therapy
About
Athersys develops regenerative medicine therapies, including MultiStem cell therapy for neurological, inflammatory, and cardiovascular conditions.
Funding History
3Total raised: $65M
Debt$15MUndisclosedMar 15, 2022
PIPE$20MUndisclosedDec 15, 2020
IPO$30MUndisclosedAug 15, 2007
Company Info
TypePrivate
Founded1995
LocationCleveland, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile